Important update on event submissions and edits01-May-2024
We are currently transitioning to a new ·¬ºÅ¿âapp events submission system and website. • New event submissions may take up to one week to be published while we complete the transition. • Editing existing events is temporarily unavailable. New edit links will be issued next week. Your patience is appreciated while we finalise these improvements to the ·¬ºÅ¿âapp events website. If you have any questions, please contact the Events Database Team eventsdatabase@rsc.org
6 June 2023 08:30 - 7 June 2023 16:55, Berlin, Germany
Introduction
This in-depth 2 day event will detail the journey of neuroscience discovery from initial lead through to clinical trials, bringing together leading companies for discussion, knowledge-sharing and focused networking.
Track 1: Therapeutic Strategies, Enabling Technologies & Biomarker Development
Advancements and emerging trends in the application of technology in developing neurological treatments
Neuroscience biomarker development
Translational approaches for drug discovery
Opportunities and challenges of designing and implementing targeted diagnostics and therapeutics
Diagnostic tool development
Track 2: Drug Discovery for Neurodegenerative Diseases
Target identification and validation approaches
Stem cell technology to fuel drug discovery
iPS cells for disease modelling and drug discovery
Blood brain barrier in CNS drug discovery
Assay Development & Screening
In vitro and in vivo disease modelling
The role of informatics in CNS drug discovery
Useful links
Speakers
Sebastien GillotinMSD, United Kingdom
Pekka KallunkiLundbeck, Denmark
Iain ChessellAstraZeneca, United Kingdom
Ludovic CollinSwitzerland
Magnus WalterAbbVie, United Kingdom
Jenny BarnettMonument Therapeutics, United Kingdom
